Key Takeaways:
- Corteva reports third quarter 2025 net sales of $2.62 billion, up 13% year over year.
- Organic sales rose 11% with strong growth in Seed and Crop Protection segments.
- Operating EBITDA increased 149% to $49 million; Operating EPS improved 53%.
- Full-year 2025 guidance raised; 2026 outlook targets $4.1 billion in Operating EBITDA.
- Company confirms plan to separate into two independent public entities in 2026.
Corteva Announces Third Quarter 2025 Financial Performance
Corteva, Inc. (NYSE: CTVA) announced financial results for the third quarter ended September 30, 2025, reporting net sales of $2.62 billion, an increase of 13% compared to the same period in 2024. Organic sales grew 11%, supported by stronger volumes in both Seed and Crop Protection.
The company recorded a GAAP net loss of $308 million, or $(0.46) per share, primarily due to seasonal and regional factors. On a non-GAAP basis, Corteva reported Operating EBITDA of $49 million, up 149% from the previous year, and an Operating EPS of $(0.23), a 53% improvement year over year.
Corteva Segment Highlights: Seed and Crop Protection
Seed Business Performance
Seed net sales reached $917 million in the third quarter, up 33% from the prior year. The increase was driven by a 27% rise in volume, a 4% improvement in price/mix, and favorable currency effects. Growth was led by early deliveries in Brazil, corn recovery in Argentina, and increased corn demand across EMEA. Segment Operating EBITDA recorded a loss of $193 million, an improvement of 40% over 2024.
Crop Protection Business Update
Crop Protection net sales totaled $1.70 billion, up 4% year over year, reflecting a 5% rise in volume and a 1% currency tailwind, offset by a 2% decline in price. Demand for new products and biologicals contributed to higher volumes, while competitive pricing in Latin America pressured results. Segment Operating EBITDA rose 13% to $279 million, driven by productivity savings and cost efficiency.
Corteva Updates 2025 Guidance and Provides 2026 Outlook
Corteva updated its 2025 full-year guidance, projecting net sales between $17.7 billion and $17.9 billion, with Operating EBITDA expected to range from $3.8 billion to $3.9 billion. Operating EPS is now forecast between $3.25 and $3.35 per share.
For 2026, Corteva provided a preliminary view of $4.1 billion in Operating EBITDA at the midpoint, representing growth of approximately 6% compared to 2025 expectations. The company also plans to repurchase about $1 billion of shares during 2025.
Corteva Outlines 2026 Separation Plans
Corteva announced its intention to separate into two independent public companies in the second half of 2026, pending customary approvals. “New Corteva” will focus on differentiated crop protection and biological products, while “SpinCo” will emphasize advanced genetics and emerging technologies such as gene editing, hybrid wheat, and biofuels.
The separation is expected to create more focused business models and greater flexibility for capital allocation. Corteva has invested $8.9 billion in research and development since 2019 and launched over 2,500 new products in Seed and Crop Protection, positioning both future companies for continued growth.
Market and Regional Overview
Regional performance showed consistent growth across most markets. North America led with a 16% increase in sales, followed by Latin America at 17% and EMEA at 11%. Asia Pacific declined 8%, impacted by reduced oilseed demand.
Corteva stated that the global agriculture market remains mixed, with stable demand but ongoing price pressure and margin constraints. The company noted that strong execution in key markets and continued investment in innovation will remain central to its strategy going forward.
Read the full financial report here.
13 Comments